New hope for tough prostate cancers: old drug targets genetic weakness
NCT ID NCT03652493
Summary
This study tested whether the chemotherapy drug carboplatin could help control advanced prostate cancer that had spread and stopped responding to standard hormone treatments. It focused on a small group of 16 men whose tumors had specific genetic changes that might make them more sensitive to this type of drug. Researchers measured whether the treatment shrank tumors and lowered PSA blood levels in these patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre François Baclesse
Caen, 14076, France
-
Centre Oscar Lambret
Lille, 59000, France
-
Chu Rouen
Rouen, 76000, France
-
Institut Gustave ROUSSy IGR
Villejuif, France
Conditions
Explore the condition pages connected to this study.